This pathway helps control appetite, fullness, digestion, and blood sugar
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality
Download the FREE Boston 25 News app for breaking news alerts
GLP-1 medications may not be appropriate for all individuals
The FDA has issued warnings about this exact issue, cautioning people not to purchase unapproved drugs labeled for research only or not for human consumption. Since retatrutide hasnt been approved yet, anything sold directly to consumers at this time could put your health at risk
Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims that implied sameness with FDA-approved medications